Norman Schwartz - Sep 1, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: Chairman, President, and CEO, Director, 10%+ Owner
Signature: /s/ Norman Schwartz
Stock symbol: BIO
Transactions as of: Sep 1, 2022
Transactions value $: -$372,954
Form type: 4
Date filed: 9/6/2022, 02:10 PM
Previous filing: Aug 29, 2022
Next filing: Sep 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+1.27K	+0.3%	$0.00	425K	Sep 1, 2022	Direct	F1
transaction	BIO	Bio-Rad A Common Stock	Tax liability	-$373K	-767	-0.18%	$486.25	424K	Sep 1, 2022	Direct
holding	BIO	Bio-Rad B Common Stock						12.9K	Sep 1, 2022	By Spouse	F2
holding	BIO	Bio-Rad B Common Stock						4.06M	Sep 1, 2022	By Blue Raven Partners, L.P.	F3
holding	BIO	Bio-Rad B Common Stock						332K	Sep 1, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Award	$0	+8.33K		$0.00	8.33K	Sep 1, 2022	Bio-Rad A Common Stock	8.33K	$0.00	Direct	F4, F5
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-1.27K	-25%	$0.00	3.8K	Sep 1, 2022	Bio-Rad A Common Stock	1.27K	$0.00	Direct	F4, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	The reporting person disclaims beneficial ownership of these shares.
F3	The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5	The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F6	On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.